Branhamella catarrhalis respiratory infections
- PMID: 1628725
Branhamella catarrhalis respiratory infections
Abstract
Branhamella catarrhalis is an aerobic Gram-negative diplococcus. It has been traditionally regarded as an oropharyngeal commensal and until recently was only identified as a pathogen in cases of bronchopulmonary infections. The aim of this study was to analyse the characteristics of the respiratory infections caused by B. catarrhalis and to know the antibiotic susceptibility of this microorganism. We retrospectively studied 32 lower respiratory tract infections, caused by B. catarrhalis (20 cases of bronchial infection and 12 cases of pneumonia), diagnosed between 1988-1989 in our hospital. All patients had an underlying disease; chronic obstructive pulmonary disease (COPD) and chronic heart disease being the most frequent. The aetiological diagnostic procedures were: sputum culture in 28 cases (15 in pure culture and 13 mixed), protected specimen brush (PSB) in three cases and transthoracic needle aspiration (TNA) in one case. Twenty B. catarrhalis isolates were penicillin and ampicillin-resistant, 11 in the pneumonia group and 9 in the bronchial infection group. All isolates were sensitive to amoxycillin-clavulanic acid and second generation cephalosporin. In our group four patients died. We conclude that B. catarrhalis is a not infrequent cause of respiratory infection, particularly in COPD patients, and that the high incidence of antibiotic resistance to penicillin and ampicillin should be taken into account before considering an empirical antibiotic treatment.
Similar articles
-
Moraxella (Branhamella) catarrhalis.Infect Dis Clin North Am. 1991 Sep;5(3):523-38. Infect Dis Clin North Am. 1991. PMID: 1955698 Review.
-
Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.Med Sci Monit. 2000 Mar-Apr;6(2):300-4. Med Sci Monit. 2000. PMID: 11208326
-
Isolation of Moraxella catarrhalis in patients at King Khalid University Hospital, Riyadh.Saudi Med J. 2000 Sep;21(9):860-3. Saudi Med J. 2000. PMID: 11376364
-
[Moraxella (Branhamella) catarrhalis: its isolation in the respiratory secretions of adult patients].An Med Interna. 1997 Nov;14(11):554-8. An Med Interna. 1997. PMID: 9445580 Spanish.
-
[Moraxella (Branhamella) catarrhalis. A common pathogenic agent].Presse Med. 1993 May 1-8;22(16):779-82. Presse Med. 1993. PMID: 8316533 Review. French.
Cited by
-
Clinical characteristics of community-acquired pneumonia due to Moraxella catarrhalis in adults: a retrospective single-centre study.BMC Infect Dis. 2020 Nov 10;20(1):821. doi: 10.1186/s12879-020-05564-9. BMC Infect Dis. 2020. PMID: 33172398 Free PMC article.
-
Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):219-34. doi: 10.1007/BF01699978. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9707304 Review.
-
Pulmonary thin-section CT findings in acute Moraxella catarrhalis pulmonary infection.Br J Radiol. 2011 Dec;84(1008):1109-14. doi: 10.1259/bjr/42762966. Epub 2010 Dec 1. Br J Radiol. 2011. PMID: 21123308 Free PMC article.
-
Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.Infect Immun. 2007 Jun;75(6):2818-25. doi: 10.1128/IAI.00074-07. Epub 2007 Apr 2. Infect Immun. 2007. PMID: 17403868 Free PMC article.
-
Moraxella catarrhalis: from emerging to established pathogen.Clin Microbiol Rev. 2002 Jan;15(1):125-44. doi: 10.1128/CMR.15.1.125-144.2002. Clin Microbiol Rev. 2002. PMID: 11781271 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical